The current valuation score of Salarius Pharmaceuticals Inc is 6.27, ranking 306 out of 398 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.03, which is -44.80% below the recent high of -0.02 and -1730.35% above the recent low of -0.63.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.